ReNeuron Group plc Stock
Your prediction
Pros and Cons of ReNeuron Group plc in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ReNeuron Group plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
ReNeuron Group plc | - | - | - | - | - | - | - |
Proteome Sciences | - | 0.000% | 0.000% | -4.762% | 6.667% | -52.663% | 233.333% |
Oxford BioMedica PLC | -3.130% | 0.000% | 67.568% | -25.600% | 52.459% | -71.385% | -51.181% |
Sareum Holdings plc | -2.560% | -5.000% | 31.944% | -72.662% | -38.211% | -74.667% | - |
Comments
News
Edison issues update on ReNeuron Group (RENE): H124 results reaffirm focus on CustomEX™
Edison issues update on ReNeuron Group (RENE): H124 results reaffirm focus on CustomEX™